Patent ID: 8637505
Filing Date: 2014-01-28
Classification: A61P,C07D

Abstract:
1. A compound of Formula (I) or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof; wherein R A Cy Cy E is (a) a bond or (b) (C R R R provided that the compound is not: (R)-6-allyl-6-(4—fluorophenyl)-3-((S)-1-(4(5-methyl-1,3,4oxadiazol-2-yl)phenyl)ethyl)-1,3-oxazinan-2-one; (S)-6-(2-Methyl-allyl)-3-{(S)-1-[4-(5-methyl-[1,3,4]oxadiazol-2-yl)-phenyl]-ethyl}-6-phenyl-[1,3]oxazinan-2-one; or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof.